Cost-effectiveness-analysis of ultrasound guidance for central venous catheterization compared with landmark method: a decision-analytic model

被引:11
|
作者
Seleznova, Yana [1 ]
Brass, Patrick [2 ]
Hellmich, Martin [3 ]
Stock, Stephanie [1 ]
Mueller, Dirk [1 ]
机构
[1] Univ Hosp Cologne AoR, Inst Hlth Econ & Clin Epidemiol, Gleueler Str 176-178, D-50935 Cologne, Germany
[2] Helios Hosp Krefeld, Dept Anaesthesiol Intens Care Med & Pain Therapy, Lutherpl 40, D-47805 Krefeld, Germany
[3] Univ Cologne, Inst Med Stat & Computat Biol, Bachemer Str 86, D-50931 Cologne, Germany
关键词
Cost-effectiveness; Ultrasound guidance; Central venous catheterization; Modelling; INTERNAL JUGULAR-VEIN; ECONOMIC-EVALUATION; CANNULATION; ACCESS; TRIAL;
D O I
10.1186/s12871-019-0719-5
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Ultrasound guidance for central venous catheterization is a commonly used alternative to the conventional landmark method. Because from the German perspective, the cost-effectiveness of ultrasound guidance is unclear, this study examined the cost-effectiveness of ultrasound guidance versus the landmark method for adults undergoing a central venous catheterization. Methods: A decision-tree based model was built to estimate the costs of averted catheter-related complications. Clinical data (e.g. arterial puncture, failed attempts) were obtained from a Cochrane review and a randomized controlled trial, whilst information about cost parameters were taken from a German hospital of maximum care. The analysis was conducted from the perspective of the German Statutory Health Insurance. Results were presented as incremental cost-effectiveness ratios. To assess the parameter uncertainty, several sensitivity analyses were performed (deterministic, probabilistic and with regard to the model structure). Results: Our analysis revealed that ultrasound guidance resulted in fewer complications per person (0.04 versus 0.17 for the landmark method) and was less expensive ((sic)51 versus (sic)230 for the landmark method). Results were robust to changes in the model parameters and in the model structure. Whilst our model population reflected approximately 49% of adults undergoing a central venous catheterization cannulation per year, structural sensitivity analyses (e.g. extending the study cohort to patients at higher baseline risk of complications, pediatric patients, or using real-time/indirect catheterization) indicated the cost-effectiveness of ultrasound guidance for a broader spectrum of patients. The results should be interpreted by considering the assumptions (e.g. target population) and approximations (e.g. cost parameters) underpinning the model. Conclusions: Ultrasound guidance for central venous catheterization averts more catheter-related complications and may save the resources of the German Statutory Health Insurance compared with landmark method.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Imaging and treatment of patients with suspected liver metastases: A decision-analytic model to assess cost-effectiveness
    Gazelle, GS
    Kuntz, KM
    Halpern, EF
    Lester, JS
    Hunink, MG
    Weinstein, MC
    RADIOLOGY, 1999, 213P : 243 - 243
  • [32] Imaging and treatment of patients with suspected liver metastases: A decision-analytic model to assess cost-effectiveness
    Gazelle, GS
    Kuntz, KM
    Halpern, EF
    Lester, JS
    Hunink, MG
    Weinstein, MC
    RADIOLOGY, 1999, 213P : 305 - 305
  • [33] Combining a Budgetary-Impact Analysis and a Cost-Effectiveness Analysis Using Decision-Analytic Modelling Techniques
    Mark J.C. Nuijten
    Frans Rutten
    PharmacoEconomics, 2002, 20 : 855 - 867
  • [34] Combining a budgetary-impact analysis and a cost-effectiveness analysis using decision-analytic modelling techniques
    Nuijten, MJC
    Rutten, F
    PHARMACOECONOMICS, 2002, 20 (12) : 855 - 867
  • [35] Subclavian central venous catheters guidance and examination by ultrasound: a randomized controlled study versus landmark method
    S Perbet
    F Grimaldi
    B Pereira
    JM Constantin
    Intensive Care Medicine Experimental, 3 (Suppl 1)
  • [36] Bimatoprost, latanoprost, and travoprost for the treatment of glaucoma: A cost-effectiveness analysis in Scandinavia using a decision-analytic health economic model
    Stewart, W. C.
    Stewart, J. A.
    Passmore, C. L.
    Mychaskiw, M. A.
    VALUE IN HEALTH, 2006, 9 (06) : A369 - A370
  • [37] Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
    Tang, Jianjun
    Liang, Yuanbo
    O'Neill, Ciaran
    Kee, Frank
    Jiang, Junhong
    Congdon, Nathan
    LANCET GLOBAL HEALTH, 2019, 7 (07): : E968 - E978
  • [38] Cost-effectiveness and cost-utility of population-based glaucoma screening in China: A decision-analytic Markov model
    Congdon, Nathan G.
    Tang, Jianjun
    Liang, Yuanbo
    O'Neill, Ciaran
    Kee, Frank
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [39] Novel strategies to prevent retained surgical sponges: A decision-analytic model predicting relative cost-effectiveness
    Regenbogen, Scott E.
    Greenberg, Caprice C.
    Resch, Stepben C.
    Kollengode, Anantha
    Cima, Robert R.
    Zinner, Michael J.
    Gawande, Atul A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2008, 207 (03) : S73 - S74
  • [40] Development and validation of a new decision-analytic model designed to evaluate the cost-effectiveness of cardiac resynchronisation therapy
    Gras, D
    Banz, K
    EUROPEAN HEART JOURNAL, 2003, 24 : 519 - 519